다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Telomir Pharmaceuticals Inc (TELO)
Telomir Pharmaceuticals Inc (TELO) 뉴스

TELO

Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TELO

일자	시간	출처	헤드라인	심볼	기업
2025/03/03	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/02/26	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/02/21	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/02/18	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/02/15	07:01	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/02/05	06:45	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/02/05	06:05	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/01/28	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2025/01/07	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/12/23	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/12/21	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/12/12	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/12/03	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/11/26	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/11/22	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/11/21	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/11/13	06:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/09/28	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/08/12	21:30	GlobeNewswire Inc.	Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/07/02	21:30	GlobeNewswire Inc.	Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/06/18	05:10	GlobeNewswire Inc.	Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/30	21:30	GlobeNewswire Inc.	Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/24	22:30	GlobeNewswire Inc.	New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ET	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/16	22:30	GlobeNewswire Inc.	Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/14	05:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/04/16	21:30	GlobeNewswire Inc.	Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/04/02	21:30	GlobeNewswire Inc.	Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/30	05:44	GlobeNewswire Inc.	UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/26	21:30	GlobeNewswire Inc.	Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/22	21:30	GlobeNewswire Inc.	Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th	NASDAQ:TELO	Telomir Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:TELO

US Dollar vs Sterling

US Dollar vs Yen

Bank of America

Health Care Select Sector

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관